The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2466/11/42/prepub Editorial support in the form of copyediting and styling the manuscript for submission were provided by Geoff Weller at Gardiner-Caldwell Communication and was funded by GlaxoSmithKline.
A full description of the rationale for inclusion of each submission is provided in Table 1.
Editorial support, including revising the paper and styling the paper for journal submission, was provided by Jane G. Murphy, PhD, of Zola Associates.
The Scottish report mentions that a submission by a patient interest group was received, but no details regarding this submission are provided [ 20].
Assistance in styling the paper for journal submission was provided by Jane G. Murphy, PhD, of Zola Associates and was funded by Pfizer Inc, New York, New York, USA.
Editorial assistance in preparation of the report for submission was provided by Paul Lane, PhD, of Evidence Scientific Solutions Ltd., Horsham, UK, and was funded by F Hoffmann-La Roche AG. Hoffmann-La Roche AG
Janet Bray, MPharmS, provided medical writing services, which were funded by Pfizer Inc. Journal charges were also met by Pfizer Inc. Editorial support to prepare the manuscript for submission was provided by UBC Scientific Solutions and funded by Pfizer Inc.
Editorial support (editing for language/spelling/grammar and consistent style; coordinating manuscript review; incorporating author revisions; formatting tables and figures; fact checking; and assistance with submission) was provided by Dominik Wolf at PAREXEL and was funded by Pfizer Inc.
Editorial support, including contributing to the first draft of the paper, revising the paper based on author comments, and styling the paper for journal submission, was provided by Linda Whetter, PhD, DVM, of Zola Associates and was funded by Pfizer Inc.
Editorial support, including contributing to the first draft of the manuscript, revising the paper based on author feedback, and styling the paper for journal submission, was provided by Jane G. Murphy, PhD, of Zola Associates and was funded by Pfizer Inc.
